Filter
682
Filtered Results: 682
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
65
New Publications
204
Language
Document type
No document type
346
Studies & Reports
128
Guidelines
102
Manuals
42
Strategic & Response Plan
41
Training Material
9
Fact sheets
9
Situation Updates
3
Resource Platforms
2
Countries / Regions
Global
36
India
35
Kenya
31
Ethiopia
27
Uganda
17
South Africa
15
Western and Central Europe
13
Nepal
11
Tanzania
11
Namibia
11
Liberia
11
Sierra Leone
10
Nigeria
10
Philippines
10
Ghana
9
Zambia
9
Rwanda
8
Bangladesh
8
Ukraine
7
Myanmar / Burma
7
Zimbabwe
6
Africa
6
Indonesia
6
Syria
5
South Sudan
5
Lesotho
4
Malawi
4
Cambodia
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Cameroon
3
Senegal
3
South–East Asia Region
3
Eswatini/ Swaziland
3
Thailand
2
Fiji
2
Laos
2
Burkina Faso
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Jordan
2
West and Central Africa
2
Vietnam
2
Botswana
2
Pakistan
2
Timor Leste/ East Timor
1
Australia
1
Benin
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Guinea
1
USA
1
Haiti
1
Lithuania
1
Belgium
1
United Kingdom
1
East and Southern Africa
1
Lebanon
1
Brazil
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
282
Key Resources
42
Clinical Guidelines
37
Public Health
30
Women & Child Health
21
Pharmacy & Technologies
9
Capacity Building
7
Toolboxes
Pharmacy
65
AMR
59
COVID-19
31
NTDs
30
HIV
29
Mental Health
28
TB
28
Planetary Health
28
Rapid Response
18
NCDs
17
Health Financing Toolbox
14
Conflict
13
Caregiver
11
Malaria
11
Ebola & Marburg
9
Global Health Education
9
Specific Hazards
6
Disability
5
Refugee
3
Natural Hazards
3
Social Ethics
2
South Sudan
1
Zika
1
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Towards the Peoples Health Assembly Book -2
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau...
Comment réussir à demander, administrer et gérer les dons de Zithromax® pour l’élimination du trachome
Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings
This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within
health financing, and...
2020 was a year like no other. Amidst on-going humanitarian crises, largely fuelled by conflict and violence but also driven by the effects of climate change – such as the largest locust infestation in a generation – the world had to contend with a global pandemic. In less than one year (March-D...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
A new publication - Waste Management during the COVID-19 Pandemic: from response to recovery - reviews current practices for managing waste from healthcare facilities, households and quarantine locations accommodating people with confirmed or suspected cases of COVID-19. Jointly produced by UNEP, th...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
Copenhagen, Denmark, 24–25 August 2017
